Malafree Tablets (Primaquine Phosphate)
Primaquine Phosphate 26.3mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
MFDS item code 200000022 · Notified 2000.03.14
This product's status changed to Approval withdrawn on 2024.03.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of malaria (P. vivax) and prevention of relapse
Malaria (P. vivax) is an infectious disease caused by the malaria parasite, and this medication is used to treat such malaria infections and prevent recurrences.
Adults: Administer 15mg of primaquine (26.3mg of primaquine phosphate) orally once daily for 14 days.
Children: Administer 0.3mg/kg of primaquine (0.5mg/kg of primaquine phosphate) orally once daily for 14 days.
The safety of this medication during pregnancy is not definitively established; therefore, pregnant women should not use it. It may be harmful to both pregnant women and the fetus, so a pregnancy test is essential before use. Effective contraception should be used to avoid pregnancy during treatment, and men are advised to use condoms during and for three months after treatment. Patients with certain systemic diseases such as rheumatoid arthritis or lupus erythematosus, or those taking medications that may affect bone marrow function should not use this medication. If dark urine or symptoms of anemia appear while taking this medication, discontinue use immediately and consult a physician. Patients with glucose-6-phosphate dehydrogenase deficiency or certain enzyme deficiencies may experience side effects such as hemolytic anemia, so caution is required. Gastrointestinal symptoms such as nausea, vomiting, abdominal discomfort, and blood-related side effects may occur; notify your doctor if any abnormal symptoms arise. Care should be taken not to exceed the prescribed dosage, and regular blood tests should be conducted during the treatment period. Breastfeeding women should only use this medication when absolutely necessary, as its safety has not been fully established. Elderly patients aged 65 and older should start at the minimum dosage considering liver, kidney, and heart function. In case of overdose, symptoms such as vomiting, abdominal cramps, and unusual blood symptoms may occur, requiring immediate medical attention.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container that blocks light at room temperature. This will help maintain the effectiveness of the medication without altering its ingredients.
Orange, film-coated, round tablets
100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.